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this study is to report the measured body exposures treated 
with single dose intra-operative electron radiation therapy 
(IOERT) in a large cohort of patients and to analyze which 
beam parameters impact the body exposure. 
Materials and Methods: During an almost 5-year period, 
more than 500 Partial Breast Irradiation (PBI) procedures 
have been performed with IOERT in our institution for pT1N0 
unicentric ductal breast carcinoma. A dose of 21 Gy was 
prescribed at the 90% isodose depth. Beam delivery was 
achieved with a Mobetron 1000 (Intraop, Sunnyvale, Ca). This 
mobile accelerator produces 4, 6, 9 and 12 MeV electron 
Beams with a 10Gy/min dose rate. Although the Mobetron is 
self-shielded device, a small component of straight X-rays 
radiation is always present during treatment delivery. In 
order to measure their body exposure coming from this 
straight radiation, three LiF Thermo-Luminescent Dosimeters 
(TLD) were positioned on each patient, respectively on the 
thyroid, on the contralateral breast and at the gonads level. 
The TLD were placed in an Aluminum container thick enough 
to provide electronic equilibrium and to stop any scattered 
electrons. TLDs were directly read just after PBI in a manual 
Harshaw reader under Nitrogen flow. 
As a comparison, the body exposure in a series of 30 BCT 
patients treated with 6 MV external beams was measured in 
the same way.  
Results: Mean doses for PBI treatments on the thyroid, 
contralateral breast and gonads were 0.82, 0.41 and 0.14 cGy 
respectively. Higher energy beam gives significant higher 
body exposure. The field size, ranging from 35 mm to 65 mm 
does not influence the body exposure. On the other hand, the 
treated quadrant has an impact on measured doses. Patients 
treated with external radiation received much higher body 
doses, from 25 times to more than 100 times higher for the 
contralateral breast. 
Conclusions: As radiation protection is concerned, IOERT is a 
safe procedure and gives very small body doses, unlikely to 
increase the carcinogenetic risk significantly, especially in 
the contralateral breast. Pregnant women might, in certain 
circumstances and with additional safety measures, be 
treated with the IOERT approach with an acceptable fetal 
dose.  
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Purpose/Objective: To evaluate the necessity of using an 
image modality in order to improve and adapt the IORT 
dosimetry based on Monte Carlo simulations. 
Materials and Methods: A model of the Intrabeam™ system 
has been previously developed with the GATE platform taking 
into account the different parts of the device. This study was 
performed on 25 patients. A preoperative CT acquisition of 
the patient breast was performed and included in the 
simulation allowing accurate dose calculation (Figure 1).  
 
During IORT, in vivo dosimetry was performed on 15 patients 
using thermoluminescent dosimeters (TLD) placed on the skin 
at 1 and 3 cm around the spherical applicator. First, 
comparison between simulation results on GATE and TLD 
measurements have been performed to confirm the dose 
prediction at the TLD locations. The dose simulated was 
recorded at the same initial position of the TLD. The depth 
dose curves between MC simulations and software computed 
doses have been compared. Then, the dosimetric influence of 
the applicator’s position was simulated: the applicator has 
been moved from 5 mm to 10 mm around its initial position. 
Finally, in addition to pre-operative CT acquisition, an 
intraoperative CT has been acquired on three patients in 
order to validate the overall dosimetric evaluation protocol.  
Results: Patient results showed a good agreement between 
clinical experiments and simulations. Indeed the relative 
mean deviation between TLD and GATE dose measurements 
was 0.1% ± 0.11% with a maximum of 0.33%. The simulation 
uncertainty was less than 1% (from 0.41% to 0.95%). Breast 
densities significantly changed the depth dose curves 
compared to the one given by the Intrabeam software which 
consider the breast as homogeneous. Considering the 
applicator displacement, the mean percentage deviation of 
the dose was 6.3% ±44.9%, 8.8% ±89% at 5 mm and 10 mm 
respectively. These results indicated that the dosimetry was 
greatly influenced when moving the applicator position due 
to the high dose fall-off of the low energy x-ray source.  
Conclusions: We proposed the use of an accurate model of 
the Intrabeam system on the GATE platform accounting for 
the tissues heterogeneities. Using a pre-surgery image 
modality could greatly optimize the dosimetry by 
determining a better applicator position. The dosimetric 
evaluation of the proposed platform with patient datasets 
supports its use for patient specific dosimetry planning. By 
this way we should be able to adapt a personalized dosimetry 
and not also prescribe the same dose to all the patients.  
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